News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
Merck & Co., Inc. Sues Teva Pharmaceutical Industries Limited to Block Generic Vytorin
March 5, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg News -- Merck & Co. and its Schering unit is suing Teva Pharmaceutical Industries Ltd. to prevent it from selling a generic version of the cholesterol drug Vytorin in the United States until 2017.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Merck & Co.
MORE ON THIS TOPIC
Vaccines
Vaccine Investors Keep Their Heads Down as Trump Cuts Shot Schedule
January 6, 2026
·
3 min read
·
Dan Samorodnitsky
Obesity
Roche Clears Obesity Pill Legal Concerns With Structure Patent Agreement
January 6, 2026
·
2 min read
·
Tristan Manalac
Legal
Investment Banker Accused of Leaking Pharma M&A Secrets in $41M Insider Trading Scheme
December 23, 2025
·
2 min read
·
Nick Paul Taylor
Drug pricing
Trump Administration Reaches Pricing Agreements With 9 More Drugmakers
December 22, 2025
·
2 min read
·
Nick Paul Taylor